Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $899.88 | 53 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $160.88 | 9 | $0 (2024) |
| Novo Nordisk Inc | $142.64 | 7 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $104.02 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $73.71 | 4 | $0 (2018) |
| Merck Sharp & Dohme LLC | $73.09 | 5 | $0 (2024) |
| Allergan Inc. | $69.89 | 4 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $58.96 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $37.58 | 3 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $36.59 | 3 | $0 (2023) |
| SCPHARMACEUTICALS INC. | $33.33 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74.30 | 4 | PFIZER INC. ($33.29) |
| 2023 | $105.32 | 6 | PFIZER INC. ($43.69) |
| 2022 | $16.91 | 1 | Novo Nordisk Inc ($16.91) |
| 2021 | $144.36 | 9 | PFIZER INC. ($67.73) |
| 2020 | $96.69 | 4 | Novo Nordisk Inc ($83.21) |
| 2019 | $178.45 | 11 | Novartis Pharmaceuticals Corporation ($40.40) |
| 2018 | $122.87 | 9 | E.R. Squibb & Sons, L.L.C. ($26.80) |
| 2017 | $160.98 | 9 | E.R. Squibb & Sons, L.L.C. ($46.91) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/20/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/06/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/30/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiology | ||||||
| 11/14/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/08/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Cardiology | ||||||
| 10/04/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/18/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/02/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/01/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Diabetes | ||||||
| 11/17/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/16/2021 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.61 | General |
| 08/03/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: WOMENS HEALTH | ||||||
| 05/18/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS, REYVOW | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: WOMENS HEALTH | ||||||
| 05/07/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Diabetes | ||||||
| 04/13/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS, REYVOW | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: WOMENS HEALTH | ||||||
| 03/31/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS, REYVOW | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: WOMENS HEALTH | ||||||
| 03/24/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: UROLOGY | ||||||
| 03/11/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/29/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $58.52 | General |
| Category: Diabetes | ||||||
| 07/21/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Diabetes | ||||||
| 02/12/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: DIABETES | ||||||
| 02/04/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $10.25 | General |
| 12/11/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.64 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 600 | 995 | $352,603 | $75,177 |
| 2022 | 15 | 1,358 | 1,985 | $321,224 | $120,170 |
| 2021 | 3 | 77 | 121 | $16,152 | $3,810 |
| 2020 | 2 | 50 | 68 | $719.00 | $184.53 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 231 | 572 | $152,074 | $34,307 | 22.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 129 | 133 | $98,036 | $17,458 | 17.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 61 | 108 | $40,989 | $9,690 | 23.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 102 | 104 | $40,704 | $8,973 | 22.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 77 | 78 | $20,800 | $4,748 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 464 | 745 | $155,123 | $57,666 | 37.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 276 | 276 | $61,923 | $34,259 | 55.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 52 | 53 | $37,643 | $8,172 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 80 | 92 | $13,409 | $4,692 | 35.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 55 | 55 | $7,644 | $3,763 | 49.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 34 | $12,274 | $2,614 | 21.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 180 | 229 | $7,099 | $2,173 | 30.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 31 | $7,812 | $1,682 | 21.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 20 | 20 | $7,440 | $1,628 | 21.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 59 | 59 | $3,268 | $1,564 | 47.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 34 | 96 | $3,840 | $889.72 | 23.2% |
| 85610 | Blood test, clotting time | Office | 2022 | 23 | 146 | $1,898 | $619.01 | 32.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 16 | 21 | $849.00 | $260.79 | 30.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 35 | 43 | $312.00 | $95.48 | 30.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 24 | 85 | $690.00 | $92.77 | 13.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 20 | 42 | $13,986 | $3,316 | 23.7% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 22 | 25 | $1,464 | $332.27 | 22.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 35 | 54 | $702.00 | $162.00 | 23.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 31 | 43 | $559.00 | $128.58 | 23.0% |
| 81003 | Automated urinalysis test | Office | 2020 | 19 | 25 | $160.00 | $55.95 | 35.0% |
About Dr. Frances Horn, DO
Dr. Frances Horn, DO is a Family Medicine healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1154313120.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frances Horn, DO has received a total of $899.88 in payments from pharmaceutical and medical device companies, with $74.30 received in 2024. These payments were reported across 53 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($899.88).
As a Medicare-enrolled provider, Horn has provided services to 2,085 Medicare beneficiaries, totaling 3,169 services with total Medicare billing of $199,342. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Bartlesville, OK
- Active Since 08/16/2005
- Last Updated 10/24/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154313120
Products in Payments
- ELIQUIS (Drug) $150.69
- XARELTO (Drug) $104.02
- Ozempic (Drug) $89.87
- PREMARIN (Drug) $67.73
- ENTRESTO (Drug) $58.96
- ZERBAXA (Drug) $56.35
- LifeVest (Device) $36.59
- FUROSCIX (Drug) $33.33
- AVYCAZ (Drug) $28.94
- JARDIANCE (Drug) $26.30
- SAMSCA (Drug) $22.35
- Vaprisol (Drug) $21.81
- TEFLARO (Drug) $21.65
- DALVANCE (Drug) $19.30
- The MetaNeb System (Device) $18.78
- MYRBETRIQ (Drug) $18.60
- DIFICID (Drug) $16.74
- CHANTIX (Drug) $16.17
- TRULICITY (Drug) $15.16
- FARXIGA (Drug) $12.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bartlesville
Mark Erhardt, D.o, D.O
Family Medicine — Payments: $7,806
Elizabeth Sherrock, M.d, M.D
Family Medicine — Payments: $6,925
Dr. Daniel Holdman, Md, MD
Family Medicine — Payments: $5,612
William Davito, D.o, D.O
Family Medicine — Payments: $4,991
Michael Vaclaw, M.d, M.D
Family Medicine — Payments: $4,027
Ashley Estep, Do, DO
Family Medicine — Payments: $3,276